Clinical trial Recruiting at 1 site Interventional Ages 50 and up

Dual-task exercise to improve thinking, walking, and balance in mild cognitive impairment

Official title: Effectiveness of an Innovative Therapeutic Exercise Program on Physical and Cognitive Function in Mild Cognitive Impairment Due to Alzheimer's Disease

Run by University of Patras · NCT07334392 · Data updated 2026-11-12

This trial will try a twice-weekly exercise program that pairs physical tasks with thinking tasks in people over 50 with amnestic mild cognitive impairment to see if it helps walking, balance, and cognition.

Quick facts

Study typeInterventional
Ages50 Years and up
SexAll
Enrollment45 (estimated)
SponsorUniversity of Patras
Academic / other
Locations1 site (Pátrai)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedAugust 30, 2026
Study endsNovember 30, 2026
Registry record updatedJanuary 12, 2026
Trial IDNCT07334392 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged over 50 with amnestic mild cognitive impairment (MoCA >20), who walk independently, have stable medications, and can understand Greek.

Probably not a fit

People with dementia, major neurological disorders (e.g., Parkinson’s, MS), clinical depression, unstable medical status, recent surgery, or who cannot attend in-person sessions are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, controlled trial compares an innovative multicomponent exercise program that emphasizes dual-task training with a therapeutic exercise program without dual-task emphasis and with an education-only control group. Participants attend supervised sessions twice weekly for three months and are tested before and after the intervention on gait, balance, and cognitive measures. Exercise intensity is monitored using the Borg Rating of Perceived Exertion every two weeks to guide progression. The primary outcomes focus on changes in gait and balance, with secondary outcomes addressing global cognition and executive attention.

Why it matters

Potential benefit: If successful, the program could lead to improved walking speed and stability, better balance, and modest gains in attention and executive function for people with mild cognitive impairment.

How similar studies have gone: Prior studies of aerobic, strength, and dual-task training in mild cognitive impairment have shown improvements in gait, balance, and some cognitive domains, though results across trials have been variable.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* individuals \> 50 years old
* people with confirmed cognitive impairment, as evidenced by values within normal limits on the Montreal Cognitive Assessment test (MOCA ) \>20
* stable medication in the last month
* independent walking

Exclusion Criteria:

* people with dementia
* people suffering from chronic mental illness (e.g. schizophrenia, bipolar disorder)
* people suffering from a neurological disorder or injuries (e.g. multiple sclerosis, Parkinson's, traumatic brain injury)
* people with clinical depression (as determined by the Neuropsychiatric Inventory (NPI) assessment and medical diagnosis)
* people who have had recent surgery
* people with insufficient knowledge of the Greek language

Where it's running

  • Department of Physiotherapy, University of Patras
    Pátrai, Greece
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.